rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-2-2
|
pubmed:abstractText |
Cannabidiol (CBD) and cannabidiol dimethyl hephtyl (CBD-DMH) were hydrogenated to give four different epimers. The new derivatives were evaluated for their ability to modulate the production of reactive oxygen intermediates (ROI), nitric oxide (NO), and tumor necrosis factor (TNF-alpha) by murine macrophages, and for their binding to the cannabinoid receptor (CB(1)). Surprisingly, we found that these derivatives exhibit good binding to CB(1). In addition hydrogenated CBD and CBD-DMH demonstrate bioactivities different from their original compounds.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-2623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1113-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16451075-Animals,
pubmed-meshheading:16451075-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16451075-Brain Stem,
pubmed-meshheading:16451075-Cannabidiol,
pubmed-meshheading:16451075-Cell Line,
pubmed-meshheading:16451075-Macrophages,
pubmed-meshheading:16451075-Male,
pubmed-meshheading:16451075-Mice,
pubmed-meshheading:16451075-Mice, Inbred BALB C,
pubmed-meshheading:16451075-Nitric Oxide,
pubmed-meshheading:16451075-Radioligand Assay,
pubmed-meshheading:16451075-Rats,
pubmed-meshheading:16451075-Reactive Oxygen Species,
pubmed-meshheading:16451075-Receptor, Cannabinoid, CB1,
pubmed-meshheading:16451075-Structure-Activity Relationship,
pubmed-meshheading:16451075-Synaptosomes,
pubmed-meshheading:16451075-Tumor Necrosis Factor-alpha
|
pubmed:year |
2006
|
pubmed:articleTitle |
New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
|
pubmed:affiliation |
Department of Pharmacology and School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel. sbs@bgu.ac.il
|
pubmed:publicationType |
Journal Article,
In Vitro
|